
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study
Affan Shoukat, Carolyn E. Bawden, Gergely Röst, et al.
Vaccine (2024) Vol. 42, Iss. 7, pp. 1768-1776
Open Access | Times Cited: 8
Affan Shoukat, Carolyn E. Bawden, Gergely Röst, et al.
Vaccine (2024) Vol. 42, Iss. 7, pp. 1768-1776
Open Access | Times Cited: 8
Showing 8 citing articles:
Respiratory syncytial virus infections in adults: a narrative review
Joanne Wildenbeest, David M. Lowe, Joseph F. Standing, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 10, pp. 822-836
Closed Access | Times Cited: 8
Joanne Wildenbeest, David M. Lowe, Joseph F. Standing, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 10, pp. 822-836
Closed Access | Times Cited: 8
Recommendation for the Use of Respiratory Syncytial Virus Vaccines
Ping‐Ing Lee, Yhu‐Chering Huang, Hsiao‐Sheng Liu, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Ping‐Ing Lee, Yhu‐Chering Huang, Hsiao‐Sheng Liu, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults
Zhanwei Du, Abhishek Pandey, Seyed M. Moghadas, et al.
Nature Medicine (2025)
Open Access
Zhanwei Du, Abhishek Pandey, Seyed M. Moghadas, et al.
Nature Medicine (2025)
Open Access
Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysis
Ashleigh R. Tuite, Alison E. Simmons, Monica Rudd, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Ashleigh R. Tuite, Alison E. Simmons, Monica Rudd, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Efficacy of anti-RSV vaccination in preventing respiratory syncytial virus disease and severe illness in older adults: a systematic review of randomized controlled trials
Ana Moreira, Ana Beatriz Ribeiro, Inês Oliveira, et al.
European Geriatric Medicine (2024)
Closed Access | Times Cited: 1
Ana Moreira, Ana Beatriz Ribeiro, Inês Oliveira, et al.
European Geriatric Medicine (2024)
Closed Access | Times Cited: 1
Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: a multi-model comparison
Monica Rudd, Alison E. Simmons, Gebremedhin Beedemariam Gebretekle, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Monica Rudd, Alison E. Simmons, Gebremedhin Beedemariam Gebretekle, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece
George Gourzoulidis, C. Tzanetakos, Argyro Solakidi, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1232-1232
Open Access
George Gourzoulidis, C. Tzanetakos, Argyro Solakidi, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1232-1232
Open Access